Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
41.51
+0.38 (0.92%)
At close: Dec 20, 2024, 4:00 PM
41.50
-0.01 (-0.02%)
After-hours: Dec 20, 2024, 4:00 PM EST

Mirum Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Market Capitalization
1,9931,376719486511553
Upgrade
Market Cap Growth
53.74%91.51%47.79%-4.80%-7.70%-
Upgrade
Enterprise Value
2,0261,378535299380429
Upgrade
Last Close Price
41.5129.5219.5015.9517.4624.52
Upgrade
PS Ratio
6.377.389.3225.40--
Upgrade
PB Ratio
8.585.535.064.042.974.25
Upgrade
P/TBV Ratio
--8.654.792.974.25
Upgrade
EV/Sales Ratio
6.607.396.9515.62--
Upgrade
Debt / Equity Ratio
1.371.240.020.020.020.03
Upgrade
Asset Turnover
0.470.370.240.07--
Upgrade
Inventory Turnover
3.833.373.50---
Upgrade
Quick Ratio
3.054.072.713.7612.568.92
Upgrade
Current Ratio
3.344.452.943.9112.809.13
Upgrade
Return on Equity (ROE)
-39.84%-83.65%-103.46%-57.47%-68.29%-60.80%
Upgrade
Return on Assets (ROA)
-9.10%-13.65%-25.33%-40.48%-33.64%-34.44%
Upgrade
Return on Capital (ROIC)
-10.65%-19.46%-61.42%-72.70%-42.14%-38.76%
Upgrade
Earnings Yield
-5.01%-11.88%-18.88%-17.27%-20.22%-9.50%
Upgrade
FCF Yield
-0.11%-5.16%-16.76%-27.31%-17.49%-7.16%
Upgrade
Buyback Yield / Dilution
-22.57%-20.31%-12.07%-20.08%-119.84%-1177.21%
Upgrade
Total Shareholder Return
-22.57%-20.31%-12.07%-20.08%-119.84%-1177.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.